Search Within

Jonathan Eric Rosenberg

Formats
  1. Meeting Abstract (283)
  2. Journal Article (195)
  3. Review (18)
  4. Correspondence (10)
  5. Editorial (5)
  6. Guidelines (4)
  7. Book Section (2)
  8. Research Letter (2)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (520)
  2. Genitourinary Oncology Service (520)
  3. Solid Tumor Oncology Division (520)
  4. Department of Pathology and Laboratory Medicine (149)
  5. Surgery (140)
  6. Urology (137)

More Groups

People
  1. Dean Bajorin (204)
  2. Gopakumar Iyer (175)
  3. Hikmat Al-Ahmadie (134)
  4. Bernard Bochner (124)
  5. David Solit (114)
  6. Min Yuen Teo (75)

More People

Years
  1. 2025 (23)
  2. 2024 (36)
  3. 2023 (32)
  4. 2022 (36)
  5. 2021 (48)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (204)
  2. Annals of Oncology (42)
  3. European Urology (20)
  4. Clinical Genitourinary Cancer (18)
  5. Clinical Cancer Research (16)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (210)
  2. Oxford University Press (47)
  3. Elsevier Inc. (39)
  4. Elsevier Science, Inc. (36)
  5. Nature Publishing Group (36)
  6. American Association for Cancer Research (35)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND
    Meeting Abstract

    Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)
    Meeting Abstract

    Tully, C. M.; Apolo, A. B.; Zabor, E. C.; Regazzi, A. M.; Ostrovnaya, I.; Rosenberg, J. E.; Bajorin, D. F.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeted sequencing of upper tract urothelial carcinoma
    Meeting Abstract

    Sfakianos, J. P.; Kim, P. H.; Iyer, G.; Cha, E. K.; Zabor, E. C.; Hakimi, A. A.; Scott, S. N.; Ramirez, R.; Hanrahan, A.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis
    Meeting Abstract

    Rosenberg, J. E.; Kim, J.; Cherniack, A.; Sougnez, C.; Meyerson, M.; Getz, G.; Weinstein, J. N.; Lerner, S. P.; Kwiatkowski, D. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets
    Meeting Abstract

    Kim, P. H.; Sfakianos, J. P.; Scott, S. N.; Iyer, G.; Cha, E. K.; Al-Ahmadie, H.; Sun, A. J.; Garcia-Grossman, I. R.; Bambury, R. M.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder
    Meeting Abstract

    Cha, E. K.; Sfakianos, J. P.; Al-Ahmadie, H.; Scott, S. N.; Kim, P. H.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.; Berger, M. F.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Efficacy of single-agent pemetrexed in platinum refractory metastatic urothelial cancer (mUC)
    Meeting Abstract

    Benjamin, D. J.; Bambury, R. M.; Chaim, J.; Zabor, E. C.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway and prognostic significance for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial cancer (UC)
    Meeting Abstract

    Bellmunt, J.; Werner, L.; Riester, M.; Van Hummelen, P.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save